An Insurer’s Program to Incentivize Generic Oncology Drugs Did Not Alter Treatment Patterns or Spending On Care
Health Affairs
Authors
Laura Yasaitis, PhD; Atul Gupta, PhD; Craig Newcomb; Era Kim; Lee Newcomer, MD; Justin Bekelman, MD
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Does counting change what counts? Quantification fixation biases decision-making
PNASNovember 12, 2024 -
Repeal of Subminimum Wages and Social Determinants of Health Among People With Disabilities
JAMA Health ForumNovember 1, 2024 -
Implementation of a Secure Firearm Storage Program in Pediatric Primary Care: A Cluster Randomized Trial
JAMA PediatricsSeptember 19, 2024 -
Emergency Medicaid enrollment after traumatic injury predicts long-term health care utilization
Journal of Trauma and Acute Care SurgerySeptember 3, 2024 -
Can nudges be leveraged to enhance diversity in organizations? A systematic review
Current Opinion in PsychologyAugust 30, 2024 -
Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans
JAMA NetworkJune 6, 2024 -
Validation of a smartphone telematics algorithm for classifying driver trips
Science DirectMay 17, 2024 -
How Can a Behavioral Economics Lens Contribute to Implementation Science?
Implementation ScienceApril 26, 2024 -
Association Between the SaFETy Score and Self-reported Firearm Violence Among Young Adults Presenting to Emergency Departments in Three Cities: A Cross-Sectional Study
Annals of Internal MedicineApril 23, 2024 -
Friends with Health Benefits: A Field Experiment
Management ScienceApril 17, 2024 -
Co-Designing Strategies To Implement Long-Acting Injectable PrEP for Sexual Minority Men in Chicago: A Study Protocol for an Innovation Tournament and Implementation Mapping
Implementation Science CommunicationsMarch 25, 2024 -
Adolescent Preferences for a Pediatric Primary Care-Based Sexually Transmitted Infection and HIV Prevention Intervention
Journal of Adolescent HealthMarch 24, 2024